ATE406165T1 - Phenylpyrimidine amine als ige inhibitoren - Google Patents
Phenylpyrimidine amine als ige inhibitorenInfo
- Publication number
- ATE406165T1 ATE406165T1 AT03704506T AT03704506T ATE406165T1 AT E406165 T1 ATE406165 T1 AT E406165T1 AT 03704506 T AT03704506 T AT 03704506T AT 03704506 T AT03704506 T AT 03704506T AT E406165 T1 ATE406165 T1 AT E406165T1
- Authority
- AT
- Austria
- Prior art keywords
- phenylpyrimidine
- amine
- ige inhibitors
- ige
- inhibitors
- Prior art date
Links
- OXPDQFOKSZYEMJ-UHFFFAOYSA-N 2-phenylpyrimidine Chemical compound C1=CC=CC=C1C1=NC=CC=N1 OXPDQFOKSZYEMJ-UHFFFAOYSA-N 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0202381A GB0202381D0 (en) | 2002-02-01 | 2002-02-01 | Organic compounds |
| GB0221953A GB0221953D0 (en) | 2002-09-20 | 2002-09-20 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE406165T1 true ATE406165T1 (de) | 2008-09-15 |
Family
ID=27665364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03704506T ATE406165T1 (de) | 2002-02-01 | 2003-01-31 | Phenylpyrimidine amine als ige inhibitoren |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US20050119255A1 (de) |
| EP (1) | EP1474146B1 (de) |
| JP (1) | JP4393198B2 (de) |
| KR (1) | KR20040081159A (de) |
| CN (2) | CN1622807A (de) |
| AR (1) | AR038368A1 (de) |
| AT (1) | ATE406165T1 (de) |
| AU (1) | AU2003206810B2 (de) |
| BR (1) | BR0307379A (de) |
| CA (1) | CA2471883C (de) |
| DE (1) | DE60323205D1 (de) |
| EC (1) | ECSP045213A (de) |
| ES (1) | ES2312749T3 (de) |
| IL (1) | IL162766A0 (de) |
| MX (1) | MXPA04007395A (de) |
| NO (1) | NO20043610L (de) |
| NZ (1) | NZ534229A (de) |
| PE (1) | PE20030983A1 (de) |
| PL (1) | PL370666A1 (de) |
| PT (1) | PT1474146E (de) |
| RU (1) | RU2004126614A (de) |
| TW (1) | TW200302728A (de) |
| WO (1) | WO2003063871A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050014753A1 (en) * | 2003-04-04 | 2005-01-20 | Irm Llc | Novel compounds and compositions as protein kinase inhibitors |
| EP1648875A1 (de) * | 2003-07-30 | 2006-04-26 | Cyclacel Limited | 2-aminophenyl-4-phenylpyrimidine als kinaseinhibitoren |
| WO2005040135A1 (ja) * | 2003-10-24 | 2005-05-06 | Ono Pharmaceutical Co., Ltd. | 抗ストレス薬およびその医薬用途 |
| US20080279829A1 (en) | 2005-09-29 | 2008-11-13 | Maximilian Woisetschlaeger | Phenyl-(4-Phenyl-Pyrimidin-2-Yl)-Amines For Enhancing Immunotolerance |
| MX2010001692A (es) | 2007-08-15 | 2010-04-22 | Cytokinetics Inc | Ciertas entidades quimicas, composiciones y metodos. |
| JP2023508909A (ja) | 2019-12-20 | 2023-03-06 | イケナ オンコロジー， インコーポレイテッド | 例えば血管新生関連障害または炎症性疾患の処置に向けたアリール炭化水素受容体（ａｈｒ）アゴニストとしての４－フェニル－ｎ－（フェニル）チアゾール－２－アミン誘導体及び関連化合物 |
| KR20240159754A (ko) * | 2023-04-28 | 2024-11-06 | 한국원자력의학원 | N-메틸피페라진 에탄올 카바메이트(N-methylpiperazine ethanol carbamate) 구조를 포함하는 신규 화합물 및 이의 용도 |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1185039A (en) | 1966-03-31 | 1970-03-18 | Ici Ltd | Pyrimidine Derivatives and Compositions containing them |
| GB2001069B (en) | 1977-07-12 | 1982-01-20 | Scras | Pyrimidine derivatives |
| AU5319479A (en) | 1978-12-22 | 1980-06-26 | Ici Australia Limited | Pyrimidinyl amino phenoxy carboxylate derivatives |
| US4351939A (en) * | 1980-10-16 | 1982-09-28 | Mead Johnson & Company | Spiro-quaternary ammonium halides and N-(2-pyrimidinyl)piperazinylalkylazaspiroalkanedione process |
| DE3270906D1 (en) * | 1982-01-14 | 1986-06-05 | Merck Patent Gmbh | Liquid crystal mixtures |
| FR2536071B1 (fr) | 1982-11-12 | 1986-07-11 | Sanofi Sa | Sels acides de 2-piperazinopyrimidine, procede pour leur preparation et compositions pharmaceutiques en contenant |
| FR2547821B1 (fr) * | 1983-06-24 | 1985-12-06 | Sanofi Sa | Sel de 2-piperazinopyrimidine, procede pour sa preparation et compositions pharmaceutiques en contenant |
| US4659363A (en) | 1983-07-25 | 1987-04-21 | Ciba-Geigy Corporation | N-(2-nitrophenyl)-2-aminopyrimidine derivatives, the preparation and use thereof |
| EP0164204A1 (de) | 1984-05-12 | 1985-12-11 | FISONS plc | Pharmazeutisch nützliche Pyrimidine |
| ATE60591T1 (de) * | 1984-06-25 | 1991-02-15 | Ciba Geigy Ag | Pyrimidinderivate wirksam als schaedlingsbekaempfungsmittel. |
| EP0233461B2 (de) | 1986-01-13 | 2002-05-29 | American Cyanamid Company | 4,5,6-Substituierte 2-Pyrimidinamine |
| DE3614060A1 (de) | 1986-04-23 | 1987-10-29 | Schering Ag | Pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide |
| US4868183A (en) | 1986-07-21 | 1989-09-19 | Otsuka Pharmaceutical Factory, Inc. | N-pyrazinyl substituted P-aminophenols |
| DE3788494D1 (de) * | 1986-10-13 | 1994-01-27 | Ciba Geigy | Harnstoffe. |
| US4826990A (en) | 1987-09-30 | 1989-05-02 | American Home Products Corporation | 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents |
| US4973690A (en) * | 1988-04-12 | 1990-11-27 | Ciba-Geigy Corporation | Novel ureas |
| US4966622A (en) * | 1988-04-12 | 1990-10-30 | Ciba-Geigy Corporation | N-phenyl-N-pyrimidin-2-ylureas |
| EP0337946B1 (de) * | 1988-04-12 | 1993-07-28 | Ciba-Geigy Ag | Harnstoffe |
| JPH02308248A (ja) * | 1989-05-24 | 1990-12-21 | Fuji Photo Film Co Ltd | アミノピリミジン系色素形成カプラーおよび該カプラーを含有するハロゲン化銀カラー写真感光材料 |
| US5521184A (en) * | 1992-04-03 | 1996-05-28 | Ciba-Geigy Corporation | Pyrimidine derivatives and processes for the preparation thereof |
| US5516775A (en) * | 1992-08-31 | 1996-05-14 | Ciba-Geigy Corporation | Further use of pyrimidine derivatives |
| EP0672035A1 (de) | 1993-10-01 | 1995-09-20 | Novartis AG | Pyrimidinaminderivate und verfahren zu deren herstellung |
| DE69434721T2 (de) | 1993-10-01 | 2006-11-09 | Novartis Ag | Pharmacologisch wirksame pyrimidinderivate und verfahren zu deren herstellung |
| DK0672041T3 (da) | 1993-10-01 | 2002-02-25 | Novartis Ag | Farmakologisk aktive pyridinderivater og fremgangsmåder til fremstilling deraf |
| PL313973A1 (en) * | 1993-10-12 | 1996-08-05 | Du Pont Merck Pharma | 1 n-alkyl-n-arylopyrimidin amines and their derivatives |
| CN1102144C (zh) | 1994-08-13 | 2003-02-26 | 株式会社柳韩洋行 | 新的嘧啶衍生物及其制备方法 |
| GB9523675D0 (en) | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
| TW520362B (en) | 1996-12-05 | 2003-02-11 | Amgen Inc | Substituted pyrimidine compounds and pharmaceutical composition comprising same |
| WO1998042699A1 (en) * | 1997-03-26 | 1998-10-01 | Taisho Pharmaceutical Co., Ltd. | 4-tetrahydropyridylpyrimidine derivatives |
| IN188411B (de) | 1997-03-27 | 2002-09-21 | Yuhan Corp | |
| US6440965B1 (en) | 1997-10-15 | 2002-08-27 | Krenitsky Pharmaceuticals, Inc. | Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system |
| WO1999035140A1 (en) * | 1998-01-12 | 1999-07-15 | Novartis Ag | PYRIDINYLPYRIMIDINE AMINES AS IMMUNOGLOBULINE E (IgE) SYNTHESIS INHIBITORS |
| EP1052238A4 (de) * | 1998-01-28 | 2007-05-02 | Shionogi & Co | Neue trizyklische verbindung |
| NZ506679A (en) | 1998-03-27 | 2002-11-26 | Janssen Pharmaceutica Nv | HIV inhibiting pyrimidine derivatives |
| AR023052A1 (es) | 1998-09-25 | 2002-09-04 | Mitsuharu Yoshimura Milton | Derivados de pirimidona |
| EP1132387B1 (de) * | 1998-11-17 | 2005-09-28 | Kumiai Chemical Industry Co., Ltd. | Pyrimidinylbenzimidazol- und triazinylbenzimidazol-derivate und agrikulte/hortikulte fungizide |
| GB9828511D0 (en) | 1998-12-24 | 1999-02-17 | Zeneca Ltd | Chemical compounds |
| DE60035271D1 (en) | 1999-04-28 | 2007-08-02 | Inst Med Molecular Design Inc | Pyrimidincarbonsäurederivate |
| GB9914258D0 (en) | 1999-06-18 | 1999-08-18 | Celltech Therapeutics Ltd | Chemical compounds |
| GB0003224D0 (en) | 2000-02-11 | 2000-04-05 | Glaxo Group Ltd | Chemical compounds |
-
2003
- 2003-01-30 AR ARP030100267A patent/AR038368A1/es not_active Application Discontinuation
- 2003-01-30 TW TW092102250A patent/TW200302728A/zh unknown
- 2003-01-31 MX MXPA04007395A patent/MXPA04007395A/es active IP Right Grant
- 2003-01-31 AU AU2003206810A patent/AU2003206810B2/en not_active Ceased
- 2003-01-31 CA CA2471883A patent/CA2471883C/en not_active Expired - Fee Related
- 2003-01-31 US US10/501,445 patent/US20050119255A1/en not_active Abandoned
- 2003-01-31 PT PT03704506T patent/PT1474146E/pt unknown
- 2003-01-31 ES ES03704506T patent/ES2312749T3/es not_active Expired - Lifetime
- 2003-01-31 PE PE2003000116A patent/PE20030983A1/es not_active Application Discontinuation
- 2003-01-31 RU RU2004126614/04A patent/RU2004126614A/ru not_active Application Discontinuation
- 2003-01-31 DE DE60323205T patent/DE60323205D1/de not_active Expired - Fee Related
- 2003-01-31 CN CNA038027372A patent/CN1622807A/zh active Pending
- 2003-01-31 JP JP2003563561A patent/JP4393198B2/ja not_active Expired - Fee Related
- 2003-01-31 WO PCT/EP2003/000973 patent/WO2003063871A1/en not_active Ceased
- 2003-01-31 NZ NZ534229A patent/NZ534229A/en unknown
- 2003-01-31 PL PL03370666A patent/PL370666A1/xx not_active Application Discontinuation
- 2003-01-31 AT AT03704506T patent/ATE406165T1/de active
- 2003-01-31 KR KR10-2004-7011797A patent/KR20040081159A/ko not_active Withdrawn
- 2003-01-31 BR BR0307379-3A patent/BR0307379A/pt not_active IP Right Cessation
- 2003-01-31 IL IL16276603A patent/IL162766A0/xx unknown
- 2003-01-31 EP EP03704506A patent/EP1474146B1/de not_active Expired - Lifetime
- 2003-01-31 CN CN200910205037A patent/CN101684097A/zh active Pending
-
2004
- 2004-07-30 EC EC2004005213A patent/ECSP045213A/es unknown
- 2004-08-30 NO NO20043610A patent/NO20043610L/no not_active Application Discontinuation
-
2007
- 2007-05-23 US US11/805,515 patent/US7759357B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1622807A (zh) | 2005-06-01 |
| KR20040081159A (ko) | 2004-09-20 |
| PT1474146E (pt) | 2008-12-05 |
| NZ534229A (en) | 2005-04-29 |
| JP2005516051A (ja) | 2005-06-02 |
| US20070281956A1 (en) | 2007-12-06 |
| TW200302728A (en) | 2003-08-16 |
| US20050119255A1 (en) | 2005-06-02 |
| MXPA04007395A (es) | 2005-06-17 |
| JP4393198B2 (ja) | 2010-01-06 |
| WO2003063871A1 (en) | 2003-08-07 |
| ECSP045213A (es) | 2004-09-28 |
| ES2312749T3 (es) | 2009-03-01 |
| DE60323205D1 (en) | 2008-10-09 |
| RU2004126614A (ru) | 2005-05-27 |
| CA2471883C (en) | 2010-12-07 |
| PE20030983A1 (es) | 2004-01-26 |
| NO20043610L (no) | 2004-10-05 |
| AU2003206810B2 (en) | 2006-06-29 |
| PL370666A1 (en) | 2005-05-30 |
| EP1474146B1 (de) | 2008-08-27 |
| AR038368A1 (es) | 2005-01-12 |
| IL162766A0 (en) | 2005-11-20 |
| US7759357B2 (en) | 2010-07-20 |
| EP1474146A1 (de) | 2004-11-10 |
| CN101684097A (zh) | 2010-03-31 |
| BR0307379A (pt) | 2004-12-28 |
| CA2471883A1 (en) | 2003-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE452891T1 (de) | Pyrimidopyrimidone als kinaseinhibitoren | |
| DE60329282D1 (de) | Cyano-pyrrolidine als DPP-IV Inhibitoren | |
| DK1487805T3 (da) | Pyrimidinderivater | |
| ATE505471T1 (de) | Azaindol-kinaseinhibitoren | |
| DE60320933D1 (de) | Rho-kinase inhibitoren | |
| ATE368651T1 (de) | Pyridazinon-derivate als gsk-3beta-hemmer | |
| IS7599A (is) | Heterósýklískir kínasatálmar | |
| DE60313872D1 (de) | Pyrazoloä1,5-aüpyrimidine als hemmstoffe cyclin-abhängiger kinasen | |
| EP1546115A4 (de) | Substituierte pyrimidine | |
| DE60325032D1 (de) | 2-hydroxy-3-heteroarylindole derivate als gsk3 inhibitoren | |
| DK1505963T3 (da) | Hepatitis C-inhibitorer | |
| ATE424383T1 (de) | Cyclische amine mit benzamidsubstituent als bace- 1-inhibitoren | |
| DE50308372D1 (de) | Bohrhammer | |
| DE602004018837D1 (de) | Ptidase-iv-inhibitoren | |
| NL1027811A1 (nl) | Heterocyclische aminen als remmers 11- -hydroxy-steroïd-dehydrogenase type 1. | |
| DE60331751D1 (de) | N-substituierte 2-oxodihydropyridinderivate als npy antagonisten | |
| EP1499336A4 (de) | Proteasehemmer | |
| DE602004012154D1 (de) | Pyridoä2,3-düpyrimidin-2,4-diamine als pde-2-inhibitoren | |
| ATE478868T1 (de) | Pyrrolodihydroisochinoline als pde10- inhibitoren | |
| ATE529428T1 (de) | Thioxanthinderivate als myeloperoxidaseinhibitoren | |
| DE60324208D1 (de) | Biarylsulfonamide als mmp-inhibitoren | |
| ATE402700T1 (de) | Glycinamid-derivate als raf-kinase-hemmer | |
| DE502004006055D1 (de) | 6-arylamino-5-cyano-4-pyrimidinone als pde9a-inhibitoren | |
| ATE384530T1 (de) | 4-aminochinolin-3-carbonsäureamid-derivate als pde4-hemmer | |
| ATE509011T1 (de) | Pyrimidinderivate als 11beta-hsd1-inhibitoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1474146 Country of ref document: EP |